Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CCZ | UMC |
|---|---|---|
| Price | $64.67 | $24.07 |
| Change today | ▲ 0.00% | ▼ 2.49% |
| Market cap | $61.26B | $60.59B |
| Return, 3 months | +2.7% | -12.6% |
| Return, year to date | +10.1% | +211.4% |
| Return, 1 year | +6.5% | +227.2% |
| P/E (TTM) | – | 23.3 |
| P/B | – | 4.3 |
| P/E percentile vs own 5y | 0th | 94th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +17.0% |
| Net profit growth (YoY) | – | +377.2% |
| Gross margin | – | 30.6% |
| Operating margin | – | 19.7% |
| Net margin | – | 32.8% |
| Return on equity | – | 21.0% |
| Analyst target vs. price | – | -45.2% |
| Analyst buy share | – | 0% |
| RSI (14) | 41 | 64 |
| 30-day volatility | 18.2% | 50.1% |
| Max drawdown, 1 year | -6.5% | -37.9% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.